INTRODUCTION
============

*Helicobacter pylori* (*H. pylori*) infection is an etiological factor for the development of peptic ulcer and gastric cancer[@B1]. Several preliminary reports have suggested that chronic infections by *H. pylori*, as well as other chronic infections, may be associated with atherosclerosis and vascular disease[@B2], [@B3]. However, most prospective studies have not confirmed the association between chronic infections and coronary artery disease (CAD)[@B4]-[@B6] and all the recent prospective studies and meta-analyses on the association between *Chlamydia pneumoniae* (*C. pneumoniae*) and/or Cytomegalovirus infection and coronary disease have produced negative results. This suggests there is only a possible mild association, and the previous studies virtually excluded a major role for *H. pylori* infection as a risk factor[@B7], [@B8]. Several studies have assessed the association between the cytotoxin-associated gene-A (CagA) status and vascular diseases (either coronary disease or cerebrovascular disease), and these studies have produced mixed results[@B9]-[@B13]. The rate of positivity for *H. pylori* infection among Korean adults is reported to reach as much as 70%[@B14]-[@B16]. Though the prevalence of coronary artery disease among Asians has been reported to not be much different from that of Caucasians, in spite of the high rate of *H. pylori* infection for both races[@B17], the exact relation between *H. pylori* and cardiovascular risk factors might be an important issue to reduce the incidence of cardiovascular disease[@B18].

The objectives of the present study were to reveal and examine the relation between the *H. pylori* infection of the stomach and CAD, and to angiographically determine, after 6 to 9 months, the influence of *H. pylori* infection on the reintervention of patients who were treated by percutaneous coronary intervention (PCI).

MATERIALS AND METHODS
=====================

The subjects of this study were those patients who were admitted to the Cardiac Catheterization Laboratory at Daejeon St. Mary\'s Hospital and Kangnam St. Mary\'s Hospital for coronary angiography, and these patients were suspected to have developed CAD; we prospectively enrolled those patients who were seen from January 2003 to June 2006. All the patients underwent physical examinations. In terms of smoking behavior, the patients were divided into two groups: smokers and non-smokers. Patients who had stopped smoking for 10 years or less were classified as smokers. The definition of hypertension was the current use of antihypertensive drugs, or it was based on the seventh report of the Joint National Committee on the Detection, Evaluation and Treatment of High Blood Pressure. Hyperlipidemia was defined as the state where the serum cholesterol level was 200 mg/dL and greater, or the current use of a hypolipidemic drug. The definition of diabetes was based on the criteria of the American Diabetes Association, or the current use of oral hypoglycemic agents or insulin. The decision to perform coronary angiography was based on those symptoms that were consistent with this diagnosis and also an abnormal electrocardiogram (either baseline or stress). Both the right and left coronary arteries were studied in at least two oblique projections (RAO 30° and LAO 60°). The CAD group that was included in the study consisted of those patients who had at least one coronary artery lesion that occupied at least 50% of the luminal diameter, as noted on the coronary angiography. The patients who had normal coronary angiographic results were selected as the normal control group. Gastroduodenoscopy was done in both groups within 1 month before or after performance of the coronary angiogram. Some patients were excluded if they had a platelet count of less than 100,000/mm^3^, acute myocardial infarction within the 48 hours, primary PCI, a history of previous treated PCI or coronary artery bypass graft or *H. pylori* eradication or malignancy. A small tiny tissue of the antrum that was taken by gastroduodenoscopic biopsy was stained via Warthin-starry silver stain. A negative staining result was defined as there was no stained tissue in the sample and the stained tissue was positive for *H. pylori* infection. More than 70% of the coronary stenotic patients in the CAD group were angiographically treated with PCI. Procedural success was defined as the final diameter of the stenosis was 35% or less and there was no flow-limiting dissection. Intracoronary stents were recommended only for those patients with suboptimal angiographic results. We angiographically followed up, at between 6 to 9 months, the patients of the CAD group who were treated by PCI and we then we evaluated their reintervention; their new stonotic lesions were due to new coronary stenotic lesion and in-stent restenosis. New coronary stenotic lesion was defined when the newly developed lumen occupied more than 50% of the vessel lumen, and in-stent restenosis was defined when the blockage was more than 50% of the stent lumen. The height and weight of each patient was measured and the body mass index (BMI) was calculated as kg/m. After more than 12 hours of fasting, a blood sample was taken before the coronary angiogram. The blood glucose level, total cholesterol, triglyceride (TG), high-density lipoprotein cholesterol (HDL-c) and low-density lipoprotein cholesterol (LDL-c) and so on were measured by an enzymatic method and using an automatic analyzer (Hitachi 747). Highly sensitive C-reactive protein (hsCRP) was measured by immunonephelometry (Nephelometry, Behring Nephelometer II, Dade Behring Marburg, Germany).

Statistical analysis
--------------------

Statistical analyses were performed with using SPSS11 statistical analysis software. Unless otherwise noted, any test of a hypothesis was two-sided and the level of significance was set at 5%. Potential associations between the clinical and biologic parameters were tested for by univariate analysis with using the Student t or the chi-square test. The results were expressed as means±SDs.

RESULTS
=======

The series originally consisted of 88 cases for the angiographically documented normal control group and 175 angiographically documented cases for the CAD group. Compared with the normal control group, the patients with CAD were significantly older and smoked more and among them, the male patients outnumbered their female counterparts; in addition, the male CAD patients had lower serum concentrations of HDL-c ([Table 1](#T1){ref-type="table"}). Twenty seven (30.7%) patients of the normal control group and 71 (40.6%) patients of the CAD group were positive for *H. pylori* infection. The incidence of *H. pylori* infection for the CAD group showed a tendency to increase, but there was no statistical difference between the groups ([Figure 1](#F1){ref-type="fig"}).

We angiographically followed up the 80 patients of the CAD group who were treated by PCI after 6 to 9 months (the re-intervention group). Twenty two (37.9%) of the 58 *H. pylori* negative patients and 10 (45.5%) of the 22 *H. pylori* positive patients were treated with reintervention, and the rate of reintervention was also not significantly different between the two groups ([Table 2](#T2){ref-type="table"}). The reintervention was caused by new coronary stenotic lesion and in-stent restenosis. New coronary stenotic lesions were noted in 18 (31.0%) of the 58 H. pylori negative patients and in 10 (45.5%) of the 22 *H. pylori* positive patients, and the number of patients with in-stent restenosis were 8 (13.8%) and 2 (9.1%), respectively. The previous stents of the in-stent restenosis patients were all bare-metal stents. There was no significant difference between the group with *H. pylori* infection and the group without the infection.

DISCUSSION
==========

Seroepidemiologic studies have demonstrated that atherosclerosis is associated with several infectious pathogens, including *H. pylori*[@B2], [@B19], *C. pneumoniae*[@B20], [@B21] and cytomegalovirus[@B22]. Both *H. pylori* infection and CAD are associated with the socioeconomic status of patients, and both *H. pylori* infection and CAD increase with age[@B23], [@B24]. Finding a causal association between the two diseases would be very important in that *H. pylori* can be screened for and it is amenable to treatment. There is also the possibility of a future vaccine that might be given in childhood and also performing eradication of *H. pylori* in adulthood. Previous studies that examined the relation of both diseases have used a variety of criteria to define the presence or absence of CAD. In addition, all of the control subjects in the other previous studies have lacked angiographic confirmation[@B2],[@B25]-[@B27]. Therefore, to minimize any misclassification of our patients, we used angiographic confirmation to determine the presence or absence of CAD in both the cases and the controls. In the other studies, the presence or absence of *H. pylori* seropositivity was used to diagnose *H. pylori* infection, yet in our study, this was diagnosed by gastroduodenoscopic biopsy[@B1], [@B2], [@B4], [@B6], [@B7].

The results of our studies revealed little association between *H. pylori* infection and CAD, but the rate of *H. pylori* infection for the CAD group showed a tendency to increase. According to a recent study, chronic infection with *H. pylori* may be involved in the development of atherosclerosis via endothelial dysfunction and systemic and vascular inflammation[@B28], and definite evidence of an association between CagA-positive *H. pylori* and ischemic heart disease will probably come about only from prospective studies. We found three group case-control studies[@B4], [@B12], [@B13] that had remarkably similar results; these studies showed the weak association between CagA-positive *H. pylori* and the occurrence of fatal and nonfatal myocardial infarction during the follow-up period, with a pooled odds ration (OR) of 1.26 (95% confidence interval: 1.05-1.51), which corresponds to a relative risk of 1.13. These findings virtually rule out any major relationship between the CagA status and ischemic heart disease. A possible limit of these studies is that they were performed in the same country with a population that had a relatively high prevalence of CagA strains. However, the reported 13% increase in the risk of cardiac events may still have significant epidemiological consequences, as infection by CagA-positive *H. pylori* is present in approximately 30% of the population. In addition, *H. pylori* may be an independent risk factor for restenosis, and other studies have reported that *H. pylori* eradication significantly attenuates the reduction in the coronary artery lumen in CAD patients after PCI[@B29], [@B30]. In our study, the relation between *H. pylori* and reintervention after PCI also had a tendency to increase, but there was no significant difference.

There are several limitations in our study. The study included a small number of patients and we lacked information about the virulence of *H. pylori*. The number and rate of the followed-up patients that underwent reintervention were also small. We believe that future studies that will focus on the virulent *H. pylori* strains in a large group of patients are needed to determine the probable role of *H. pylori* for CAD and restenosis.
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Comparison of the demographics and coronary risk factors of the normal control group and the coronary artery disease group
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*p*, *p*-value; NS, non-significant; CAD, coronary artery disease; BMI, body mass index; FBS, fasting blood sugar; Cr, creatinine; T-chol, total cholesterol; TG, triglyceride; HDL-c, high density lipoprotein cholesterol; LDL-c, low density lipoprotein cholesterol; hsCRP, Highly sensitive C-reactive protein; SD, standard deviation
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Reintervention after percutaneous coronary intervention according to the status of *Helicobacter pylori* infection
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